Biopharmaceutical Development and Production Week

IBC’s Biopharmaceutical Development and Production Week provides updates on current and emerging methods to improve your bioproduction capabilities and delivers strategies to help you overcome process challenges and accelerate production of the biopharmaceutical industry’s emerging new wave of monoclonal antibodies (MAbs) and novel molecules.

Methods

The Monday and Tuesday tracks provide a firm foundation in practical methods and strategies for specific unit operations. This can help you tackle some of the specific challenges in your job function. Implement process validation and continuous verification in the new paradigm. Leverage contract manufacturing and technology transfer for improved bioproduction. Prepare to meet future demands for analytical technologies. Control raw material variability and improve supply chain transparency. Mitigate contamination risk with viral safety strategies to meet regulatory standards.

Molecules

The Wednesday–Friday tracks provide you with the most comprehensive update on the expanding variety of new molecules progressing through company pipelines, including a review of the technical complexities and opportunities presented by each class of molecule. Improve existing and design new upstream processes for today and tomorrow. Enter the new age of biopharma with next-generation downstream processes. Develop biosimilars that meet speed, cost-efficiency, and similarity criteria. Implement the facility of the future with manufacturing strategies and life-cycle management. Streamline the path from development to commercial success for antibody–drug conjugates (ADCs). Transform bispecific antibody design, development, and production.

New This Year

Four regulatory presenters (representing the US Food and Drug Administration and the European Medicines Agency) bring you up-to-date information on regulatory expectations. An Rx-360 panel discussion on preventing raw material adulteration helps you protect your biomanufacturing operations. Migrate from MAbs to next-generation biologics with ADCs: revolutionary approaches to help you overcome the challenges and accelerate production of this promising new class of molecules. Develop biosimilars with speed and cost efficiencies. Gain development and market access (strategies for global and emerging markets). Transform bispecific antibody design, development, and production to improve molecule design, solubility, stability, and half-life; develop platform processes; and achieve superior functionality. Embrace innovation with manufacturing and life-cycle management coverage. Determine the impact of regulatory trends, new technology implementation, and the facility of the future (and what that means for current facilities).

Plenary Keynotes

Testimonials

“I greatly enjoyed the quality of the case studies presented. The speakers were very open to sharing ideas and lessons learned from real-world projects.” —M. Pujols (manufacturing director at MedImmune, LLC)

“Good topics, good people, and discussions on the point!” —J. Friedle (managing director of Atoll GmbH)

“Biopharmaceutical Development and Production Week provides a fluid representation of the changing landscape of our industry, allowing networking and topical discussion around our industry’s current state of the art and the relevant challenges of the day.” —Bryan D. Monroe (process science fellow at Life Technologies)

“These well-organized conferences cover the key topics and areas of interest across the biotech industry. They provide an excellent forum to exchange ideas and create networking contacts.” —W. D. Taylor (director of business development at Pfenex)

BPI Subscribers Save

IBC has designed two, three, and five-day conference passes to fit all your needs. Find complete details online, or call 1-800-309-4078. When registering, please mention priority code BPIDEC12 and save 20% off standard rates. This offer is for new registrations only and cannot be combined with other offers.